Product Information

PRAVASTATIN SODIUM 20 MG TAB is a generic product labeled by Cipla USA Inc., priced at $0.0620 per EA under NDC 69097078912. Its NADAC has been published 98 times since Oct 9, 2024.

FDA first approved this application on May 11, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PRAVASTATIN SODIUM 20 MG TAB

PRAVASTATIN SODIUM
$0.0620per EA

Strength

20 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097078912

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PRAVASTATIN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA077987

FDA Approved

5/11/2007

TE Code

AB

On Market Since

6/1/2024

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for PRAVASTATIN SODIUM 20 MG TAB has been published 98 times since Oct 9, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0620 per EA
All-time high$0.0715 (Sep 10, 2025)
All-time low$0.0505 (Nov 20, 2024)
52-week high$0.0715
52-week low$0.0612
Median price$0.0642
Average price$0.0641
Largest weekly change-19.1% (Nov 20, 2024)
Weeks tracked98
Tracking sinceOct 9, 2024

Price History

1W

-0.9%

1M

-0.9%

3M

+1.3%

6M

-3.5%

1Y

-13.4%

3Y

N/A

5Y

N/A

All

+1.8%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PRAVASTATIN SODIUM 20 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for PRAVASTATIN SODIUM 20 MG TAB, manufactured by Cipla USA Inc., is $0.0620 per EA (NDC 69097078912), effective Aug 19, 2026.

How has the price of PRAVASTATIN SODIUM 20 MG TAB changed over time?

Over the history we have for it, the NADAC for PRAVASTATIN SODIUM 20 MG TAB has held within roughly two percent of its current level. It has been tracked across 98 weekly CMS publications since Oct 9, 2024.

What are the highest and lowest recorded NADAC prices for PRAVASTATIN SODIUM 20 MG TAB?

Since Oct 9, 2024, the NADAC for PRAVASTATIN SODIUM 20 MG TAB has ranged from a low of $0.0505 (Nov 20, 2024) to a high of $0.0715 (Sep 10, 2025), with a median of $0.0642 per EA.

Are there cheaper alternatives to PRAVASTATIN SODIUM 20 MG TAB?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PRAVASTATIN SODIUM 20 MG TAB, is $0.0519 per EA — about 16% below PRAVASTATIN SODIUM 20 MG TAB.

Who manufactures PRAVASTATIN SODIUM 20 MG TAB?

PRAVASTATIN SODIUM 20 MG TAB (NDC 69097078912) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.